Healthcare provider profile · identity verified

Stuart G Hannah, MD

Family Practice · BARABOO, WI · NPI 1164488839

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	518	153
Omeprazole	Omeprazole	321	88
Lisinopril	Lisinopril	281	80
Amlodipine Besylate	Amlodipine Besylate	224	59
Levothyroxine Sodium	Levothyroxine Sodium	211	51
Rosuvastatin Calcium	Rosuvastatin Calcium	208	62
Metoprolol Tartrate	Metoprolol Tartrate	199	54
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	190	35
Pantoprazole Sodium	Pantoprazole Sodium	182	58
Furosemide	Furosemide	178	48
Tamsulosin Hcl	Tamsulosin Hcl	173	53
Metformin Hcl Er	Metformin Hcl	172	41
Gabapentin	Gabapentin	164	44
Losartan Potassium	Losartan Potassium	164	52
Simvastatin	Simvastatin	162	48
Hydrochlorothiazide	Hydrochlorothiazide	151	46
Metoprolol Succinate	Metoprolol Succinate	142	45
Metformin Hcl	Metformin Hcl	132	35
Eliquis	Apixaban	130	24
Warfarin Sodium	Warfarin Sodium	130	32
Oxycodone Hcl	Oxycodone Hcl	124	19
Tramadol Hcl	Tramadol Hcl	121	21
Potassium Chloride	Potassium Chloride	113	31
Trazodone Hcl	Trazodone Hcl	112	31
Glimepiride	Glimepiride	94	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	41
Fluticasone Propionate	Fluticasone Propionate	92	36
Trulicity	Dulaglutide	88	11
Lorazepam	Lorazepam	87	14
Jardiance	Empagliflozin	86	22
Allopurinol	Allopurinol	84	22
Clopidogrel	Clopidogrel Bisulfate	83	24
Atenolol	Atenolol	82	17
Escitalopram Oxalate	Escitalopram Oxalate	81	21
Famotidine	Famotidine	72	23
Clonazepam	Clonazepam	64	suppressed
Mirtazapine	Mirtazapine	61	11
Spironolactone	Spironolactone	61	14
Carvedilol	Carvedilol	60	20
Ozempic	Semaglutide	60	11
Xarelto	Rivaroxaban	60	15
Ezetimibe	Ezetimibe	58	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	18
Baclofen	Baclofen	57	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	11
Citalopram Hbr	Citalopram Hydrobromide	48	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	25
Montelukast Sodium	Montelukast Sodium	45	13
Aripiprazole	Aripiprazole	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	13
Prednisone	Prednisone	43	12
Finasteride	Finasteride	42	15
Fluoxetine Hcl	Fluoxetine Hcl	42	14
Pregabalin	Pregabalin	42	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	11
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Ventolin Hfa	Albuterol Sulfate	37	19
Nitroglycerin	Nitroglycerin	35	19
Nystatin	Nystatin	35	14
Mounjaro	Tirzepatide	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Sertraline Hcl	Sertraline Hcl	34	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Alprazolam	Alprazolam	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Amoxicillin	Amoxicillin	27	13
Benazepril Hcl	Benazepril Hcl	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Morphine Sulfate	Morphine Sulfate	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Glipizide	Glipizide	23	suppressed
Ondansetron Odt	Ondansetron	23	12
Bupropion Xl	Bupropion Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Lovastatin	Lovastatin	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Flunisolide	Flunisolide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Primidone	Primidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error